Nutlin-3a, the first molecule described targeting MDM2, inhibits the interaction between Mdm2 and p53 [178], eventually arrests cell cycle, inhibits growth of cancer cells, and induces cell death in vitro and in vivo. Here, TP53 is linked to cancer.